The Food and Drug Administration (FDA) is responsible for the regulation of the pharmaceutical industry in the interest of protecting public health. The FDA ensures that high standards for drug efficacy and safety are applied to products available to the consumers and patients. When it comes the development of new drugs and therapeutic biological products, FDA’s Center for Drug Evaluation and Research (CDER) has the major role. Each year, CDER approves a wide range of new drugs and biological products. Let us hear about those of utmost relevance to us as practicing physicians from Dr. Denis Xavier, Head - Division of Clinical Research and Training at St.John's Medical College.  Join in LIVE as we discuss the new molecular entities and new therapeutic biological products approved in 2022 and its implications for clinical practice.

Key FDA Updates 2022

Professor of Pharmacology, St. John's Medical College | Ex-Vice Dean (PG) St. John's Medical College | Head, Division of Clinical Research and Training, St. John's Research Institute

Dr. Denis Xavier

1

471

8.6K

4.5

Sessions Taken

471

4.5